Copeland Capital Management LLC Takes $966,000 Position in Lam Research Corporation $LRCX

Copeland Capital Management LLC purchased a new position in shares of Lam Research Corporation (NASDAQ:LRCX) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 7,216 shares of the semiconductor company’s stock, valued at approximately $966,000.

Several other institutional investors have also added to or reduced their stakes in the company. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the 2nd quarter valued at $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research during the 2nd quarter worth $27,000. Strategic Wealth Investment Group LLC acquired a new stake in Lam Research in the second quarter valued at about $29,000. Delos Wealth Advisors LLC bought a new position in Lam Research in the second quarter valued at about $30,000. Finally, REAP Financial Group LLC acquired a new position in Lam Research during the second quarter worth about $31,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on LRCX. Citigroup raised their price target on shares of Lam Research from $175.00 to $190.00 and gave the company a “buy” rating in a research note on Tuesday, November 11th. JPMorgan Chase & Co. raised their target price on shares of Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a research report on Thursday, October 23rd. Dbs Bank boosted their target price on shares of Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. Jefferies Financial Group reissued a “buy” rating and set a $200.00 price objective (up previously from $175.00) on shares of Lam Research in a report on Monday, December 15th. Finally, Sanford C. Bernstein boosted their price objective on Lam Research from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Friday, November 21st. Twenty-six investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and an average target price of $161.21.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $173.78 on Wednesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $179.80. The firm has a market cap of $218.27 billion, a PE ratio of 38.28, a price-to-earnings-growth ratio of 2.03 and a beta of 1.77. The firm’s fifty day moving average is $159.60 and its 200-day moving average is $127.64.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same period last year, the company earned $0.86 EPS. Lam Research’s revenue for the quarter was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Sell-side analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.6%. Lam Research’s dividend payout ratio is presently 22.91%.

Insider Buying and Selling

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Ava Harter sold 9,010 shares of Lam Research stock in a transaction on Monday, October 27th. The stock was sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This represents a 13.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 102,608 shares of company stock valued at $14,916,496. Insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.